Diabetes Type 1

This comprehensive presentation provides an in-depth overview of Type 1 Diabetes (T1D)—a chronic autoimmune condition resulting from immune-mediated destruction of pancreatic β-cells, leading to absolute insulin deficiency. It covers the epidemiology, risk factors, symptoms, and systemic complications associated with T1D. The presentation also examines current diagnostic method and diabetes management such as insulin-based therapies. Furthermore, it introduces cutting-edge regenerative and integrative solutions, including Precursor Stem Cell Therapy (PSCT), Autologous Active Specific Immunotherapy (AASI®), Nano Organo Peptides (NOP) Thymus and Mito Organelle (MO) Thymus for Thymus Therapy, Nano Organo Peptides (NOP) Super Transfer Factor (STF), Mito Organelles (MO) Super Transfer Factor (STF), and GcMAF Forte. Supported by scientific references and clinical case studies, this presentation is designed for healthcare professionals, researchers, and educators aiming to deepen their expertise in diabetes autoimmunity and next-generation therapeutic strategies.